Signa Vitae. 2026; 22(3): 163-163. doi: 10.22514/sv.2026.042
Correction

Correction: Curcumin exerts anti-inflammatory, antioxidant and anti-ferroptotic effects through the Nrf2/HO-1 pathway to protect cardiomyocytes against sepsis

Yao Shi1, Xiaobo Yang2,*,, Hong Jiang3, Shanxia Wu1, Yan Hong3, Wei Su3, Xuan Wang1

1Department of Pediatrics, Key Laboratory for Molecular Diagnosis of Hubei Province, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, 430014 Wuhan, Hubei, China

2Department of Ophthalmology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430022 Wuhan, Hubei, China

3Department of Neonatology, Key Laboratory for Molecular Diagnosis of Hubei Province, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, 430014 Wuhan, Hubei, China

*Corresponding Author(s):yxb02441981@163.com (Xiaobo Yang)

History Published: 08 August 2026
Copyright:  ©2026 The Author(s). Published by MRE Press.
This is an open access article under the CC BY 4.0 license (https://creativecommons.org/licenses/by/4.0/).

Collapse table of contents

Abstract

No abstract available.

Keywords:None.
PDF(115.21 kB)|EndNote (RIS)|BibTeX|RefMan|RefWorks

Cite this article

Shi Y, Yang X, Jiang H, Wu S, Hong Y, Su W, Wang X. Correction: Curcumin exerts anti-inflammatory, antioxidant and anti-ferroptotic effects through the Nrf2/HO-1 pathway to protect cardiomyocytes against sepsis. Signa Vitae. 2026; 22(3): 163-163. doi: 10.22514/sv.2026.042

In the originally published article [1] (DOI: 10.22514/sv.2024.057), post-publication review by the Editorial Office identified that References [1], [5], [10], [16], and [32] were inappropriate or did not fully support the corresponding statements.

In collaboration with the authors, the following corrections have been made in this Correction:

The following references have been replaced with more relevant citations:

[1] replaced by: Chiu C, Legrand M. Epidemiology of sepsis and septic shock. Current Opinion in Anesthesiology. 2021; 34: 71–76.

[5] replaced by: Kim SJ, Mesquita FCP, Hochman-Mendez C. New biomarkers for cardiovascular disease. The Texas Heart Institute Journal. 2023; 50: e238178.

[10] replaced by: Kar F, Yıldız F, Hacioglu C, Kar E, Donmez DB, Senturk H, et al. LoxBlock-1 or Curcumin attenuates liver, pancreas and cardiac ferroptosis, oxidative stress and injury in Ischemia/reperfusion-damaged rats by facilitating ACSL/GPx4 signaling. Tissue & Cell. 2023; 82: 102114.

[16] replaced by: Vieira BM, Caetano MAF, de Carvalho MT, Dos Santos Arruda F, Tomé FD, de Oliveira JF, et al. Impacts of curcumin treatment on experimental sepsis: a systematic review. Oxidative Medicine and Cellular Longevity. 2023; 2023: 2252213.

[32] replaced by: Yang Y, Yang P, Zheng Z, Tian Q. Sestrin2 ameliorates LPS-induced cardiomyocyte injury by inhibiting ferroptosis via the Nrf2/HO-1 pathway. European Journal of Medical Research. 2025; 31: 3.

The authors confirm that these corrections do not affect the scientific content, results, interpretations, or conclusions of the original study.

The authors sincerely apologize for these inaccuracies and any inconvenience caused. This Correction has been approved by the Editor-in-Chief. The original article PDF remains available as published and has not been altered. Readers are advised to refer to this Correction for the updated references [1], [5], [10], [16], and [32].

References

Shi Y, Yang XB, Jiang H, Wu SX, Hong Y, Su W, et al. Curcumin exerts anti-inflammatory, antioxidant and anti-ferroptotic effects through the Nrf2/HO-1 pathway to protect cardiomyocytes against sepsis. Signa Vitae. 2024; 20: 46–53.

[Google Scholar]